Hadil M. Alahdal

Riyadh, 11671, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Differential Expression and Target Gene Analysis of PBMC-Derived microRNAs as Prognostic Biomarkers in Acute Lymphoblastic Leukemia.

Differential Expression and Target Gene Analysis of PBMC-Derived microRNAs as Prognostic Biomarkers in Acute Lymphoblastic Leukemia.

Journal: International journal of molecular sciences
Published: March 16, 2026

Unveiling the neuroprotective effects of pomegranate extract and/or physical activity against aluminum chloride-induced Alzheimer's disease in rats: modulation of multitude pathways.

Unveiling the neuroprotective effects of pomegranate extract and/or physical activity against aluminum chloride-induced Alzheimer's disease in rats: modulation of multitude pathways.

Journal: Frontiers in pharmacology
Published: January 21, 2026

Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways.

Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways.

Journal: PloS one
Published: October 02, 2025

Green synthesis of spheroid silver nanoparticles using cyanobacteria with multifunctional biological activities.

Green synthesis of spheroid silver nanoparticles using cyanobacteria with multifunctional biological activities.

Journal: Scientific reports
Published: July 22, 2025

Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer.

Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer.

Journal: Frontiers in oncology
Published: March 24, 2025

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer's Disease.

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer's Disease.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 17, 2025

Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins.

Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 10, 2024

Natural Inhibitors of Salmonella MDR Efflux Pumps AcrAB and AcrD: An Integrated In Silico, Molecular, and In Vitro Investigation.

Natural Inhibitors of Salmonella MDR Efflux Pumps AcrAB and AcrD: An Integrated In Silico, Molecular, and In Vitro Investigation.

Journal: International journal of molecular sciences
Published: October 25, 2024

Correction: Chromosome 16p11.2 microdeletion syndrome with microcephaly and Dandy-Walker malformation spectrum: expanding the known phenotype.

Correction: Chromosome 16p11.2 microdeletion syndrome with microcephaly and Dandy-Walker malformation spectrum: expanding the known phenotype.

Journal: Human genomics
Published: October 15, 2024

T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.

T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.

Journal: International journal of molecular sciences
Published: September 20, 2024

Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.

Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.

Journal: Biomolecules
Published: March 13, 2024

Chromosome 16p11.2 microdeletion syndrome with microcephaly and Dandy-Walker malformation spectrum: expanding the known phenotype.

Chromosome 16p11.2 microdeletion syndrome with microcephaly and Dandy-Walker malformation spectrum: expanding the known phenotype.

Journal: Human genomics
Published: December 20, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026